What is the evidence for use of zinc to aid wound healing?

Comment by InpharmD Researcher

While there is limited high-quality clinical data supporting the use of zinc in wound care management, zinc is an endogenous trace element that regulates immunomodulatory and epithelial proliferative effects, playing a key role in wound healing. Of zinc formulations evaluated for use in wound healing, topical zinc oxide was positively associated with an increased wound healing rate in patients with and without zinc deficiency. Pooled data have also found zinc to significantly improve healing rates compared to control in patients with pressure injuries.

Background

The use of zinc in wound healing has been studied for its cellular and molecular mechanisms in modulating the healing process. A 2017 review article discusses zinc's role in this context, highlighting its importance in wound healing through two lenses, the consequences of zinc deficiency and the potential benefits of topical and systemic zinc supplementation. Zinc deficiency is linked to delayed healing, and it is suggested that addressing it can lead to improved outcomes, especially in at-risk patients. A typical treatment approach includes a loading dose of 10–30 mg and a daily maintenance dose of 2.5-5 mg. However, the effects of zinc supplementation in individuals without deficiency are less well-defined, with limited high-quality studies available. For instance, some evidence suggests that oral zinc does not enhance healing in patients with arterial or venous ulcers, while one meta-analysis indicates that topical zinc oxide (6-15%) improved healing in chronic venous leg ulcers, though findings were derived from small and low-quality studies. [1]

In wound care, zinc therapy is suggested to be beneficial for zinc-deficient patients due to the loss of zinc during injury. Common formulations include topical zinc sulfate (ZnSO4) at a 3% concentration, known for its antioxidant properties, as well as 1% zinc chloride and insoluble zinc oxide, which offers prolonged zinc release and enhances healing. Zinc oxide also aids in collagen degradation in necrotic wounds and induces mRNA expression of metallothionein, contributing to its anti-UV protective effects. For severe burn patients, a typical regimen involves daily zinc supplementation of 22 mg or more. Recent advancements in zinc oxide nanoparticle technology show promise for wound treatment due to their effective cell penetration and immunomodulatory and antimicrobial properties. Nevertheless, the authors emphasize that further research into the pharmacodynamics and toxicology of these nanoparticles is crucial before they can be widely implemented. [1]

Zinc is an essential trace element with critical physiological, enzymatic, and structural functions, tightly regulated by families of zinc importers, exporters, and binding proteins. To further understand the role of zinc in wound healing, another 2017 review discussed biological functions regulated by zinc and its role in wound management. Physiological processes involving zinc have been predominantly identified in experimental animal models including rats and pigs. Results from these studies have shown that zinc is markedly increased during the first 24 hours post-injury, peaks during epithelial proliferation, and is attributed to elevated metallothionein (MT) expression in wound margin keratinocytes, macrophages, and dermal fibroblasts. While topical zinc oxide application was shown to promote healing in animals with and without a zinc deficiency, topical zinc sulfate showed no benefits and even impaired healing at higher concentrations. [2]

Clinical studies indicate that while oral zinc supplementation lacks definitive evidence for healing chronic leg ulcers, topical zinc oxide demonstrates increased wound healing and reepithelialization in patients with and without low serum zinc levels. Additionally, zinc oxide serves as an effective debridement agent for pressure ulcers, diabetic foot ulcers, and burns. However, due to the limited sample size, more extensive research is needed to fully understand its applications and benefits across various patient populations. While zinc toxicity is rare, zinc deficiency affects over 2 billion people globally, leading to symptoms such as impaired growth, taste, smell, night vision, and poor wound healing. The study authors concluded that the use of oral zinc supplementation and topical zinc sulfate does not improve wound healing rates, whereas topical zinc oxide enhances healing regardless of the patient’s zinc status. Overall, further studies are needed to explore the therapeutic potential of zinc in wound care. [2]

In order to assess the efficacy of zinc supplementation in patients with pressure injuries, a 2020 meta-analysis evaluated seven studies (N= 473 patients) that compared zinc supplementation to a control nutrition intervention. The zinc therapies used in the intervention groups included specific nutrition approaches, protein-lipid-zinc oral formula, compound sulfadiazine zinc, sulfadiazine zinc ointment, silver zinc cream, and zinc oxide oil. The analysis found a significant improvement in healing rates for the intervention group compared to the control group, with a relative risk of 1.44 (95% confidence interval 1.01 to 2.06; p= 0.043; I2= 19.3%). Additionally, all included studies showed significant improvement in Pressure Ulcer Scale for Healing scores of pressure injuries. Based on these findings, it was suggested that zinc therapy may potentially promote wound healing and should be considered for patients during pressure injury treatment. [3]

Zinc as a topical formulation for the acceleration of wound healing has been explored in both ex vivo and in vitro models for its antimicrobial and anti-inflammatory properties. Among these, a 2021 human ex vivo model study evaluated the efficacy and mechanism of ZnSO4 in epidermal wound healing exhibited in healthy volunteers (N= 30) with suction blister wounds. This randomized, double-blinded, three-arm trial compared topical zinc gel (1.4%), gel placebo, and distilled water applied to induced wounds once daily for 4 days before biopsy and immunohistochemistry analysis. Results suggested that topical ZnSO4 increased keratinocyte migration and Zn-dependent matrix metalloproteinase-1 (MMP-1) expression of the neoepidermis (new skin growth over wound) but not in any other epidermal compartment. Additionally, MT was shown to be upregulated in the neoepidermis and non-epithelialized wound beds. This leads to the possibility that ZnSO4 topical application enhances MMP-1 expression leading to cell migration and MT upregulation, resulting in anti-inflammatory processes on the wound surface. Notably, no significant differences were seen between treatment groups on neoepidermis formation on day 4 prior to biopsy. [4]

As zinc is one of the key metal ions involved in wound healing that promotes protein synthesis, cell division, and immune function regulation, several recent animal studies have evaluated the efficacy of zinc via in vivo and in vitro testing. One study investigated the use of a topical arginine and zinc controlled-release hydrogel on wound recovery rate for 13 days in a mice model. By day 13, wounds treated with the zinc combination hydrogel were nearly completely healed (96.59%) when compared to a blank control group (68.61%). An additional mice model study tested topical zinc nanocomposites for antimicrobial efficacy and rate of wound healing. Zinc nanocomposites were tested for antibacterial properties in pathogens commonly seen in acute and chronic wounds with low inhibitory activity overall. Zinc nanocomposite-treated mice showed faster wound healing at day 7 (73%) and complete wound closure by day 10 of treatment. Another study tested multiple sprayable hydrogel systems for sustained release of multi-metallic ions (calcium, copper, and zinc) at a wound site and assessed for wound healing efficacy in a rat model. The zinc-containing hydrogel spray showed rapid wound healing within 6 days of treatment, increased collagen deposition and angiogenesis at wound site compared to the multi-metallic ion-free hydrogel; these findings are limited by the use of other endogenous metallic released by the body during wound healing. Overall, study results show potential benefits for topical zinc use in wound care management but require further testing for safety and clinical outcomes in humans. [4], [5], [6], [7]

References:

[1] Lin PH, Sermersheim M, Li H, Lee PHU, Steinberg SM, Ma J. Zinc in Wound Healing Modulation. Nutrients. 2017;10(1):16. Published 2017 Dec 24. doi:10.3390/nu10010016
[2] Kogan S, Sood A, Garnick MS. Zinc and Wound Healing: A Review of Zinc Physiology and Clinical Applications. Wounds. 2017;29(4):102-106.
[3] Song YP, Wang L, Yu HR, et al. Zinc Therapy Is a Reasonable Choice for Patients With Pressure Injuries: A Systematic Review and Meta-Analysis. Nutr Clin Pract. 2020;35(6):1001-1009. doi:10.1002/ncp.10485
[4] Ågren MS, Chafranska L, Eriksen JO, et al. Spatial expression of metallothionein, matrix metalloproteinase-1 and Ki-67 in human epidermal wounds treated with zinc and determined by quantitative immunohistochemistry: A randomised double-blind trial. Eur J Cell Biol. 2021;100(3):151147. doi:10.1016/j.ejcb.2020.151147
[5] Sun Q, Dong X, Meng Q, Xu J, Wang T. Reversible Schiff Base Chemistry in Arginine-Grafted Regenerated Cellulose Hydrogel: Integration of Chitosan and Zinc Ions for Enhanced Hemostasis, Antibacterial Action, and Accelerated Wound Healing. ACS Appl Bio Mater. Published online September 23, 2024. doi:10.1021/acsabm.4c01196
[6] Rodzik A, Pomastowski P, Buszewska-Forajta M, et al. Enhancing wound healing with zinc and silver nanocomposites synthesized with β-lactoglobulin: antimicrobial properties, collagen deposition, and systemic effects in a C57BL/6J mouse model. Discov Nano. 2024;19(1):150. Published 2024 Sep 17. doi:10.1186/s11671-024-04091-9
[7] Ghosal D, Majumder N, Das P, et al. Enhancing Wound Healing With Sprayable Hydrogel Releasing Multi Metallic Ions: Inspired by the Body's Endogenous Healing Mechanism. Adv Healthc Mater. Published online September 3, 2024. doi:10.1002/adhm.202402024

Literature Review

A search of the published medical literature revealed 3 studies investigating the researchable question:

what is the evidence for use of zinc to aid wound healing?

Level of evidence

A - Multiple high-quality studies with consistent results  Read more→



Please see Tables 1-3 for your response.


Multinutrient Supplementation Increases Collagen Synthesis during Early Wound Repair in a Randomized Controlled Trial in Patients with Inguinal Hernia

Design

Single-center, open-label, prospective randomized controlled trial

N= 21

Objective

To evaluate the effect of perioperative multi-nutrient supplementation (containing arginine, glutamine, vitamin C, and zinc) on collagen synthesis in patients undergoing elective inguinal hernia repair

Study Groups

Multinutrient (n= 10)

Control (n= 11)

Inclusion Criteria

Aged ≥ 18 years; referred for elective, primary open inguinal hernia repair performed with the Lichtenstein technique

Exclusion Criteria

Undergone previous surgery in the same groin within the last 5 years; received systemic corticosteroid treatment; known dementia, dysregulated diabetes (glycated hemoglobin [HbA1c] >9%), hepatic disease, renal disease, or a cancer diagnosis within the last 5 years

Methods

Eligible patients who were scheduled for Lichtenstein inguinal hernia repair in Denmark were assigned to multi-nutrient supplementation or no multi-nutrient supplementation. The multinutrient group received 14 g L-arginine, 14 g L-glutamine, 1,250 mg vitamin C, and 55 mg zinc daily starting 14 d before surgery and ending 14 d after surgery. The control group received 2 g arginine, 3 g glutamine, 2 mg vitamin C, and 0 mg zinc daily in the same time period.

The multinutrient and control groups received high-quality protein to ensure a daily intake of 1.5 g protein/kg. Collagen biosynthesis was measured by the biomarkers type I procollagen propeptide (CICP), type III procollagen propeptide (PRO-C3), and type V procollagen propeptide (PRO-C5) in the sera on days -14, 0, and 1, and in the wound fluids on postoperative days 1 and 2. Compliance was recorded after the 28-day intervention period.

Duration

Screening period: January 20, 2016, to January 10, 2017

Supplementation period: 28 days

Follow up: 1 year 

Outcome Measures

Time to complete healing; postoperative complications occurring within postoperative day 30; diagnosis and/or reoperation for hernia recurrence within 1 year postoperatively

Baseline Characteristics

 

Multinutrient (n= 10)

Control (n= 11)

 

Age, years

53.2 ± 3.5 56.7 ± 4.4  

Body mass index, kg/m2

25.7 ± 1.0 24.5 ± 0.9  

Current smoker

Diabetes

2

1

2

0

 

Type of inguinal hernia

Direct

Indirect

 

5

4

 

8

3

 

Duration of surgical procedure, min

55.2 ± 11.6 47.4 ± 4.7  

Length of surgical incision, cm

7.8 ± 0.5 8.4 ± 0.5  

The compliance with supplement intake among the groups was not significantly different (95 ± 2.5%, multi-nutrient vs. 98 ± 1.0%, control; p= 0.27).

Results

Endpoint

Multinutrient (n= 10)

Control (n= 11)

p-value

Median healing time of the epidermal wounds, day

7.8  7.5 0.87

Within the first 30 postoperative days, 1 patient in the multinutrient group and 2 control patients developed a surgical site infection that required antibiotic treatment.

Within 1 year, the patient in the multi-nutrient group with surgical site infection and 3 other control patients reported hernia recurrence. These 4 patients all underwent primary surgery for a direct inguinal hernia.

Adverse Events

The study did not specifically report adverse events related to the multinutrient supplementation. However, it was noted that the supplement was well tolerated by the patients. There was no detailed mention of specific safety concerns or adverse effects during the study period.

Two patients expressed an unpleasant taste of the supplements (n=1 from each group).

Study Author Conclusions

In conclusion, perioperative oral multinutrient supplementation of arginine, glutamine, vitamin C, and zinc maintained type V collagen synthesis systemically following inguinal hernia repair and increased early type I collagen synthesis in wounds. A larger trial is warranted to confirm whether these early changes in the collagen profile translate into improved wound healing and long-term clinical outcomes after inguinal hernia repair.

InpharmD Researcher Critique

The trial was limited by its small sample size and short duration, which did not allow for measuring long-term effectiveness or safety. While the study provides valuable insights into the potential benefits of multi-nutrient supplementation, further research is needed to establish the clinical relevance of each individual supplement during the process of wound healing.

References:

Kjaer M, Frederiksen AKS, Nissen NI, et al. Multinutrient Supplementation Increases Collagen Synthesis during Early Wound Repair in a Randomized Controlled Trial in Patients with Inguinal Hernia. J Nutr. 2020;150(4):792-799. doi:10.1093/jn/nxz324

 

A Retrospective Study Of Touchless Spray For Pediatric Perineal Burns Treatment

Design

Retrospective study

N= 52

Objective

To evaluate the outcomes of patients treated with zinc oxide/dimethicone preparation for perineal burns compared to silver sulfadiazine

Study Groups

Zinc oxide/ dimethicone (n= 25)

Silver sulfadiazine (n= 27)

Inclusion Criteria

Superficial second-degree scald burns seeking treatment <24 hours after injury

Exclusion Criteria

Not explicitly stated 

Methods

The perineum was defined as extending beyond its typical anatomical boundaries, including the genitalia and both buttocks. All patients received initial treatment from the burn team with follow-up in an outpatient burn clinic. The control group included patients who received silver sulfadiazine prior to the implementation of zinc oxide/dimethicone at the burn center. Burn surgeons assessed the wounds to determine when they were fully healed. Data collected from electronic medical records included patient demographics, burn mechanism, time to presentation, total body surface area burned, surface area of the injury, burn depth, and burn cause.

Duration

Zinc oxide/ dimethicone: January 1, 2016 to October 28, 2019

Silver sulfadiazine: January 1, 2014 to December 31, 2015

Outcome Measures

Time to healing

Baseline Characteristics

 

Zinc oxide/ dimethicone (n= 25)

Silver sulfadiazine (n= 27)

 

Age, years

 4.91 ± 5.19  4.94 ± 5.12  

Female

 14  10  

Race

White

Black 

 

10 

10

 

18

  

Time to presentation, hours

3.06 ± 2.65 5.31 ± 6.93  

Total % TBSA*

3.51 ± 3.04 7.18 ± 7.86  

Buttock % TBSA

 0.35 ± 0.62 0.83 ± 1.26  

Perineal % TBSA*

0.46 ± 0.35 0.28 ± 0.31  

Study area % TBSA**

0.81 ± 0.70 1.11 ± 1.13  

Abbreviation: TBSA = Total body surface area

*Statistcially significant difference between both groups

**“Study area” represents the combined perineal and buttock regions.

Results

Endpoint

Zinc oxide/ dimethicone (n= 25)

Silver sulfadiazine (n= 27)

p-Value

Time to healing, days

 12.16  ± 8.64  16.90 ± 11.34  0.04

Adverse Events

Common Adverse Events: No allergic reactions or infections were observed or reported

Study Author Conclusions

Our results showed significantly less time to healing with the zinc oxide/dimethicone treatment versus the silver sulfadiazine treatment. This result is promising although total body surface area burn may have been negatively affecting healing time in the control group. Importantly, zinc oxide/dimethicone was not inferior to silver sulfadiazine, but further studies are needed to determine whether a zinc oxide/dimethicone preparation in of itself is superior to silver sulfadiazine for treatment of burns in general, or whether the other factors such as hands-off application and occlusivity of the product play a role in shortening healing times.

InpharmD Researcher Critique

Healing time may have been overestimated since it was measured in days between weekly clinic visits, potentially affecting both groups unequally. The control group had a significantly larger total body burn area, which could have prolonged healing time, and may reflect selective treatment when zinc oxide/dimethicone was first introduced. While the total burn area of the buttocks and studied region was similar, the intervention group had larger perineal burns, which could have influenced healing due to differences in tissue type. Additionally, at-home treatment, patient compliance, and unaccounted remedies were difficult to control, potentially affecting outcomes. 



References:

Diab WC, Ridelman E, Vitale L, Cloutier D, Klein JD, Shanti CM. A Retrospective Study of Touchless Spray for Pediatric Perineal Burns Treatment. J Burn Care Res. 2022;43(2):408-411. doi:10.1093/jbcr/irab138

 

The effects of zinc supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial

Design

Randomized, double-blind, placebo-controlled trial

N= 60

Objective

To determine the effects of zinc supplementation on wound healing and metabolic status in patients with diabetic foot ulcer

Study Groups

Placebo (n= 30)

Zinc (n= 30)

Inclusion Criteria

Age 40-85 years, grade 3 diabetic foot ulcer (DFU)

Exclusion Criteria

Pregnant and breastfed patients, consumed zinc supplements during previous 3 months, change in consuming medications throughout the study, history of diseases that influence the development of DFU including chronic trauma

Methods

Patients were randomized to receive either 220 mg of zinc sulfate (equivalent to 50 mg of elemental zinc) or placebo daily for 12 weeks. Throughout the study, all participants followed a standardized diabetic foot care protocol according to IDSA guidelines while maintaining their usual physical activity levels and avoiding nutritional supplements. Medication containers were collected to ensure adherence to supplement intake, and participants received daily reminders via cell phone. Compliance was further confirmed by measuring serum zinc levels.

Duration

August 2015 to November 2015

Outcome Measures

Primary: wound healing and markers of insulin metabolism 

Secondary: biomarkers of inflammation

Baseline Characteristics

 

Placebo (n= 30)

Zinc (n= 30)

 

Age, years

60.0 ± 10.0 58.3 ± 8.6  

Female

9 (30%) 9 (30.0%)  

BMI, kg/m2

25.8 ± 3.1 25.8 ± 3.0  

Zinc, mg/day

9.9 ± 2.7 9.7 ± 2.4  

Results

Endpoint

Placebo (n= 30)

Zinc group (n= 30)

p-value

Change in ulcer parameters, cm

Length

Width

Depth

 

-0.9 ± 1.2

-0.8 ± 1.0

-0.3 ± 1.0

 

-1.5 ± 0.7

-1.4 ± 0.8

-0.8 ± 0.6

 

0.02

0.02

0.05

Ulcer symptoms

Erythema

Discharge

Necrosis

 

11 (36.7%)

5 (16.7%)

3 (10%)

 

9 (30%)

3 (10%)

1 (3.3%)

 

0.58

0.44

0.25

Change in biomarkers of inflammation

hs-CRP, µg/ml

ESR, mm/h

 

-6.8 ± 21.3

-13.3 ± 28.4

 

-20.4 ± 24.6

-34.6 ± 28.5

 

0.02

0.005

Change in oxidative stress

NO, μmol/L

TAC, mmol/L

 

1.8 ± 8.2

-111.9 ± 188.7

 

6.5 ± 11.2

91.7 ± 213.9

 

0.07

<0.001

Abbreviations: ESR, erythrocyte sedimentation rate; hs-CRP, high-sensitivity C-reactive protein; NO, nitric oxide; TAC, total antioxidant capacity

Adverse Events

Not disclosed

Study Author Conclusions

Zinc supplementation for 12 weeks among diabetic foot ulcer patients had beneficial effects on parameters of ulcer size and metabolic profiles.

InpharmD Researcher Critique

This study had a small sample size, which likely limits external validity and generalizability. However, due to the inclusion of a control group, conclusions regarding the effects of zinc can be clearly extrapolated.



References:

Momen-Heravi M, Barahimi E, Razzaghi R, Bahmani F, Gilasi HR, Asemi Z. The effects of zinc supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. Wound Repair Regen. 2017;25(3):512-520. doi:10.1111/wrr.12537